scutellarin has been researched along with Acute Confusional Senile Dementia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, JH; Li, JT; Li, Z; Zeng, YQ; Zhang, XB | 1 |
| Chu, M; Feng, H; Ge, X; He, M; Lu, C; Wang, Q; Wu, L; Xia, H | 1 |
| Chen, J; Dai, Z; Fu, X; Li, H; Li, L; Li, Y; Liu, T; Luo, K; Wu, D; Zhao, Y | 1 |
| An, H; Huang, Y; Lv, S; Peng, D; Shao, W; Wang, L; Wang, Y; Wei, D; Zhang, S; Zhang, Z | 1 |
| Dolezal, R; Hrabinova, M; Janockova, J; Jost, P; Jun, D; Kaping, D; Korabecny, J; Kuca, K; Kucera, T; Mezeiova, E; Muckova, L; Sepsova, V; Soukup, O; Spilovska, K | 1 |
| Chledzik, S; Matuszek, K; Nazaruk, J; Strawa, J | 1 |
| Cui, YB; Gu, JH; Liang, C; Zeng, YQ; Zhou, XF | 1 |
| Du, M; He, J; Hu, X; Kou, L; Sun, X; Teng, S; Wang, X | 1 |
| Deng, Y; Li, Y; Liu, Q; Qiang, X; Sang, Z; Tan, Z; Xiao, G | 1 |
| Bi, CW; Chen, JJ; Cheung, AW; Choi, RC; Dong, TT; Jiang, ZY; Li, J; Tsim, KW; Xie, HQ; Zhu, JT | 1 |
| Guo, LL; Huang, Y; Wang, YL | 1 |
| Deng, J; Guan, ZZ; Guo, LL; Huang, Y; Wang, YL | 1 |
1 review(s) available for scutellarin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Pharmacological Effects of Scutellarin, An Active Component of Genus Scutellaria and Erigeron: A Systematic Review.
Topics: Alzheimer Disease; Apigenin; Brain Ischemia; Databases, Bibliographic; Diabetic Angiopathies; Erigeron; Gastritis; Glucuronates; Helicobacter Infections; Helicobacter pylori; Humans; Myocardial Ischemia; Phytotherapy; Scutellaria | 2018 |
11 other study(ies) available for scutellarin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Breviscapine exerts neuroprotective effects through multiple mechanisms in APP/PS1 transgenic mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Disease Models, Animal; DNA-Binding Proteins; Drugs, Chinese Herbal; Flavonoids; Hippocampus; Insulysin; MAP Kinase Signaling System; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Nerve Growth Factors; Neurons; Neuroprotective Agents; Plant Extracts; Receptor for Advanced Glycation End Products | 2020 |
Effects of breviscapine on amyloid beta 1-42 induced Alzheimer's disease mice: A HPLC-QTOF-MS based plasma metabonomics study.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Biomarkers; Cholesterol; Chromatography, High Pressure Liquid; Disease Models, Animal; Flavonoids; Male; Maze Learning; Metabolic Networks and Pathways; Metabolomics; Mice; Mice, Inbred ICR; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments; Phospholipids; Serotonin; Tandem Mass Spectrometry; Tryptophan | 2017 |
Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Animals; Antioxidants; Apigenin; Carbamates; Cholinesterase Inhibitors; Drug Design; Glucuronates; Mice; Neuroprotective Agents; Rats; Structure-Activity Relationship | 2022 |
Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apigenin; Brain-Gut Axis; Cognitive Dysfunction; Disease Models, Animal; Gastrointestinal Microbiome; Glucuronates; Histones; Inflammation; Interleukin-1beta; Mice; Mice, Transgenic; Presenilin-1 | 2022 |
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.
Topics: Acetylcholinesterase; Alzheimer Disease; Apigenin; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Enzyme Activation; Glucuronates; Humans; Molecular Docking Simulation; Structure-Activity Relationship; Tacrine | 2017 |
Scutellarin Mitigates Aβ-Induced Neurotoxicity and Improves Behavior Impairments in AD Mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Apigenin; Brain; Cell Line; Cognitive Dysfunction; Disease Models, Animal; Female; Glucuronates; Humans; Male; Mice; Treatment Outcome | 2018 |
Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis.
Topics: Alzheimer Disease; Animals; Antioxidants; Apigenin; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Caspase 3; Cell Line; Disease Models, Animal; Glucuronates; Glutamic Acid; L-Lactate Dehydrogenase; Male; Matrix Metalloproteinases; Mice; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species | 2018 |
Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Apigenin; Blood-Brain Barrier; Butyrylcholinesterase; Carbamates; Cell Line; Chelating Agents; Cholinesterase Inhibitors; Cognition; Glucuronates; Humans; Mice; Molecular Docking Simulation; Neuroprotective Agents; Rats | 2015 |
Estrogenic and neuroprotective properties of scutellarin from Erigeron breviscapus: a drug against postmenopausal symptoms and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apigenin; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Erigeron; Estrogen Receptor alpha; Glucuronates; Humans; Neuroprotective Agents; PC12 Cells; Phosphorylation; Phytoestrogens; Phytotherapy; Plant Extracts; Postmenopause; Rats | 2009 |
[Effect of scutellarin on expressions of nicotinic acetylcholine receptor protein and mRNA in the brains of dementia rats].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apigenin; Brain; Disease Models, Animal; Female; Glucuronates; Learning; Male; Memory; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Up-Regulation | 2011 |
[Influence of scutellarin on oxidative stress and neuronal apoptosis of rats with dementia].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apigenin; Apoptosis; Asarum; Cerebral Cortex; Dementia; Disease Models, Animal; Female; Glucuronates; Hippocampus; Male; Maze Learning; Memory; Neurons; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Superoxide Dismutase | 2011 |